Neumora
-
Second schizophrenia treatment discovered at Vanderbilt’s Warren Center enters phase I clinical trial
A new potential treatment for schizophrenia discovered through the Warren Center for Neuroscience Drug Discovery at Vanderbilt University has entered phase 1 clinical trials, marking the fifth WCNDD therapeutic to advance into human testing. Read MoreNov. 12, 2025